As of December 2025 Relmada Therapeutics has a market cap of ยฃ0.23 Billion. This makes Relmada Therapeutics the world's 7875th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 9th, 2025 the market cap of Relmada Therapeutics was reported to be: